(NASDAQ: QURE) Uniqure Nv's forecast annual revenue growth rate of 76.45% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.04%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.92%.
Uniqure Nv's revenue in 2024 is $15,843,000.On average, 5 Wall Street analysts forecast QURE's revenue for 2024 to be $1,742,269,976, with the lowest QURE revenue forecast at $334,867,925, and the highest QURE revenue forecast at $5,061,289,495. On average, 5 Wall Street analysts forecast QURE's revenue for 2025 to be $2,342,161,944, with the lowest QURE revenue forecast at $641,032,885, and the highest QURE revenue forecast at $6,123,299,200.
In 2026, QURE is forecast to generate $4,774,259,845 in revenue, with the lowest revenue forecast at $3,731,385,450 and the highest revenue forecast at $5,817,134,240.